Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors

Checkpoint inhibitors act by blocking physiologic mechanisms coopted by tumor cells to evade immune surveillance, restoring the immune system’s ability to identify and kill malignant cells. These therapies have dramatically improved outcomes in multiple tumor types with durable responses in many pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenton, Sarah E., Sosman, Jeffrey A., Chandra, Sunandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992532/
https://www.ncbi.nlm.nih.gov/pubmed/35582566
http://dx.doi.org/10.20517/cdr.2019.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992532/
https://www.ncbi.nlm.nih.gov/pubmed/35582566
http://dx.doi.org/10.20517/cdr.2019.28

Ejemplares similares